Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Cryptochromes mediate rhythmic repression of the glucocorticoid receptor.

Nature | 2011

Mammalian metabolism is highly circadian and major hormonal circuits involving nuclear hormone receptors display interlinked diurnal cycling. However, mechanisms that logically explain the coordination of nuclear hormone receptors and the clock are poorly understood. Here we show that two circadian co-regulators, cryptochromes 1 and 2, interact with the glucocorticoid receptor in a ligand-dependent fashion and globally alter the transcriptional response to glucocorticoids in mouse embryonic fibroblasts: cryptochrome deficiency vastly decreases gene repression and approximately doubles the number of dexamethasone-induced genes, suggesting that cryptochromes broadly oppose glucocorticoid receptor activation and promote repression. In mice, genetic loss of cryptochrome 1 and/or 2 results in glucose intolerance and constitutively high levels of circulating corticosterone, suggesting reduced suppression of the hypothalamic-pituitary-adrenal axis coupled with increased glucocorticoid transactivation in the liver. Genomically, cryptochromes 1 and 2 associate with a glucocorticoid response element in the phosphoenolpyruvate carboxykinase 1 promoter in a hormone-dependent manner, and dexamethasone-induced transcription of the phosphoenolpyruvate carboxykinase 1 gene was strikingly increased in cryptochrome-deficient livers. These results reveal a specific mechanism through which cryptochromes couple the activity of clock and receptor target genes to complex genomic circuits underpinning normal metabolic homeostasis.

Pubmed ID: 22170608 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIDDK NIH HHS, United States
    Id: K01 DK090188-01
  • Agency: NIDDK NIH HHS, United States
    Id: DK057978
  • Agency: NIDDK NIH HHS, United States
    Id: U19 DK062434-01
  • Agency: NIDDK NIH HHS, United States
    Id: R37 DK057978-22
  • Agency: NIDDK NIH HHS, United States
    Id: DK062434
  • Agency: NIDDK NIH HHS, United States
    Id: U19 DK062434
  • Agency: NIDDK NIH HHS, United States
    Id: K01 DK090188
  • Agency: NIDDK NIH HHS, United States
    Id: R37 DK057978
  • Agency: Howard Hughes Medical Institute, United States
  • Agency: NCI NIH HHS, United States
    Id: P30 CA014195
  • Agency: NIDDK NIH HHS, United States
    Id: DK090188
  • Agency: NIDDK NIH HHS, United States
    Id: K01 DK090188-02

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Salk Institute Razavi Newman Integrative Genomics and Bioinformatics Core Facility (IGC) (tool)

RRID:SCR_014842

Core facility established to assist the Salk community with integrating genomics data into their research. The primary focus of the core is to provide analysis support for next-generation sequencing applications.

View all literature mentions